NeurologyLive® Mind Moments®

143 Episodo

1. Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy

   Publicado: 29/3/2024
2. 111: Reviewing ACTRIMS 2024

   Publicado: 22/3/2024
3. 110: Differential Diagnosis of Sleep Disorders and Hypersomnias

   Publicado: 8/3/2024
4. 109: AB126, Exosomes, and Cerebroprotection for Stroke

   Publicado: 23/2/2024
5. 108: Advancing the Genetic Pool of Parkinson Disease

   Publicado: 9/2/2024
6. 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers

   Publicado: 26/1/2024
7. 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis

   Publicado: 12/1/2024
8. 105: Recapping Conversations in Neurology From 2023

   Publicado: 29/12/2023
9. 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2

   Publicado: 15/12/2023
10. 103: Advancing Epilepsy Care and Seizure Localization in Pediatrics

    Publicado: 1/12/2023
11. 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease

    Publicado: 17/11/2023
12. Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy

    Publicado: 7/11/2023
13. 101: Ways to Enhance Neuromodulation in Parkinsonism

    Publicado: 3/11/2023
14. Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis

    Publicado: 23/10/2023
15. 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

    Publicado: 20/10/2023
16. 99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy

    Publicado: 5/10/2023
17. 98: Uncovering Phenotypical Features of Narcolepsy Type 1

    Publicado: 22/9/2023
18. 97: Identifying Gaps in Access to Parkinson Disease Care

    Publicado: 8/9/2023
19. 96: Complexities With Cognitive Screening in Primary Care Settings

    Publicado: 25/8/2023
20. Special Episode: Addition of Valbenazine to Treat Huntington Disease Chorea

    Publicado: 21/8/2023